Ultima Genomics
DNA sequencing platforms (UG200 series) for labs, genomics service providers and research institutions
Highlights
- New on EvolcAdded 2026-11-14
About Ultima Genomics
Ultima Genomics develops high-throughput DNA sequencing platforms, including the UG200 Series with single-wafer and dual-wafer configurations, along with Solaris 2.0 library prep workflows and a sequencing analysis server.
Its customers are research and clinical genomics users, served directly through its Technology Access Program and through a network of Certified Service Providers. The company sells sequencing instruments and offers access to sequencing on its own fleet.
The company is headquartered in Fremont, California, and has open roles in Fremont, Phoenix, Abu Dhabi and remote US locations. It states it has raised over $700 million from investors. Current openings cover instrument production, chemistry, firmware, electrical and software engineering, field service and sales.
Product: UG200 and UG200 Ultra high-throughput DNA sequencing platforms with Solaris 2.0 workflows.
Jobs at Ultima Genomics
More biotech & pharma companies
Universal DX
Develops blood-based early cancer detection tests for clinical and healthcare partnersNew on EvolcValo Health
AI-enabled drug discovery and development for pharmaceutical and biotech partnersNew on EvolcVaxart
Develops oral pill vaccines for infectious diseases for public health and healthcare marketsNew on EvolcVaxcyte
Clinical-stage vaccine developer making pneumococcal, Group A Strep and Shigella vaccines for children and at-risk adultsRemote-friendlyVerastem
Develops and commercializes targeted cancer therapies for patients with RAS/MAPK pathway-driven cancersNew on EvolcViatris
Global pharmaceutical company supplying generic, branded and innovative medicines to patients and healthcare markets worldwide
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
- MouseflowMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content management
- SanityMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Frontend frameworks
- AstroMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Hosting
- NetlifyHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-nf-request-id
- Response headerx-nf-request-id
- Response headerx-nf-request-id
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.